Nocturia Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Nocturia market size was valued at USD 2198.4 million in 2022 and is forecast to a readjusted size of USD 3454.8 million by 2029 with a CAGR of 6.7% during review period.

Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.

Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.

This report is a detailed and comprehensive analysis for global Nocturia market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Sale Channels. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Nocturia market size and forecasts, in consumption value ($ Million), 2018-2029
Global Nocturia market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Nocturia market size and forecasts, by Type and by Sale Channels, in consumption value ($ Million), 2018-2029
Global Nocturia market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nocturia
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Nocturia market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Astellas Pharma
   Allergan
   Ferring Pharmaceuticals
   Eli Lilly
   GlaxoSmithKline
   Sanofi
   Pfizer
   Abbott
   Teva
   Mylan
   Johnson & Johnson
   Hainan Zhonghe Pharmaceutical

   Desmopressin
   Anticholinergic Drugs
   Alpha Blockers
   Diuretics
   Others

   Hospital Pharmacies
   Retail Pharmacies
   Online Pharmacies

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the Nocturia Market in 2025?

The Nocturia market in 2025 will benefit from advanced treatments, such as improved pharmacological solutions and minimally invasive procedures, that provide better management of the condition. Increased awareness and early diagnosis will drive demand for treatment options. Moreover, growing healthcare investments and innovations in drug development will further bolster the market's expansion.

What are the weaknesses of the Nocturia Market in 2025?

A major weakness could be the high cost of treatment, especially with newer therapies, which may limit access for a significant portion of the population. Additionally, many existing treatment options have side effects, which could discourage patient adherence. There is also a lack of universal, standardized treatment guidelines for Nocturia, leading to varied patient outcomes.

What opportunities exist in the Nocturia Market in 2025?

There is a significant opportunity for the development of non-invasive, patient-friendly treatments, such as wearable devices or personalized medicine. As the elderly population continues to grow, there will be an increasing need for effective solutions to manage nocturia. Collaborative efforts between healthcare providers and pharmaceutical companies can open new avenues for innovation and market growth.

What threats could impact the Nocturia Market in 2025?

Economic pressures, including rising healthcare costs and regulatory challenges, could limit the market's growth. Additionally, the introduction of generic drugs could decrease the profitability of proprietary treatments. There's also the threat of competition from alternative therapies or lifestyle interventions that could shift patient preferences away from traditional medical treatments.

What are the political factors affecting the Nocturia Market in 2025?

Government healthcare policies, including funding for elderly care and research into urological conditions, will influence the market. Changes in healthcare regulations and reimbursement policies for nocturia treatments could either foster or hinder market growth. Political stability and healthcare infrastructure in different regions will also play a key role in patient access to treatments.

How do economic factors impact the Nocturia Market in 2025?

Economic factors such as healthcare spending, disposable income, and the cost of treatments will directly affect patient accessibility. The market could face challenges if healthcare budgets are reduced or if insurance coverage for nocturia treatments becomes more restrictive. On the other hand, economic growth in emerging markets could create opportunities for the expansion of treatment options and availability.

What social factors influence the Nocturia Market in 2025?

An aging population and growing awareness of nocturia will drive the market. Social stigma surrounding urinary conditions may affect patient willingness to seek treatment, but increasing societal openness about health issues will likely encourage more individuals to seek help. Patient education and support groups will also play a role in enhancing treatment adherence.

What technological factors are relevant to the Nocturia Market in 2025?

Innovations in diagnostic tools and minimally invasive treatments will greatly influence the nocturia market. Technological advances in telemedicine, remote monitoring, and personalized medicine could offer more efficient and tailored treatment options. Ongoing development in drug delivery systems and wearable devices will also offer new avenues for managing the condition.

What environmental factors impact the Nocturia Market in 2025?

Environmental factors like climate change and urbanization could influence the prevalence of nocturia, as lifestyle and environmental factors affect overall health. Increased air pollution and changes in diet and physical activity could contribute to rising incidences of related health issues, thus potentially affecting nocturia rates.

How do legal factors affect the Nocturia Market in 2025?

Regulations concerning drug approval, patent protections, and medical device standards will shape the development of new treatments. Legal frameworks surrounding intellectual property rights could impact the pricing and availability of innovative treatments for nocturia. Additionally, any legal changes regarding patient privacy and data protection could affect how healthcare providers monitor and treat nocturia.

Who are the suppliers in the Nocturia Market in 2025?

Suppliers include pharmaceutical companies that develop and manufacture drugs for nocturia treatment, medical device manufacturers providing diagnostic tools and monitoring equipment, and research organizations that contribute to new treatment innovations. Suppliers also include healthcare providers, such as hospitals and clinics, offering care and management services for patients.

What inputs are required in the Nocturia Market in 2025?

The key inputs involve raw materials for drug manufacturing, clinical research data, and technological advancements for diagnostics and treatments. Additional inputs include healthcare infrastructure, patient data, and regulatory approvals for new treatments and devices. Medical expertise and ongoing research in urology are also critical to input.

What processes are involved in the Nocturia Market in 2025?

Key processes include drug development, clinical trials, regulatory approval, marketing, and distribution of treatments. Healthcare providers diagnose and treat patients, using both pharmacological and non-pharmacological methods. The process also involves post-market surveillance, patient education, and ongoing care.

Who are the customers in the Nocturia Market in 2025?

Customers primarily include patients suffering from nocturia, particularly the elderly population and those with underlying conditions. Healthcare providers, such as urologists, general practitioners, and hospitals, also act as customers by purchasing treatments and devices to manage the condition. Insurers and healthcare payers also play a significant role in facilitating patient access to care.

What are the outputs in the Nocturia Market in 2025?

Outputs in this market are effective treatments, including medications, medical devices, and diagnostic tools, that help manage nocturia symptoms. Additionally, market outputs include enhanced patient outcomes, improved quality of life for sufferers, and greater market penetration for pharmaceutical companies and healthcare providers offering specialized care.

What is the threat of new entrants in the Nocturia Market in 2025?

The threat of new entrants is moderate. While there is a growing demand for nocturia treatments, the high costs associated with research, development, and regulatory approvals make it difficult for new players to enter the market. However, advancements in technology and new approaches to treatment could create opportunities for smaller or innovative companies to enter.

What is the bargaining power of suppliers in the Nocturia Market in 2025?

The bargaining power of suppliers is relatively high. Key suppliers include pharmaceutical manufacturers, medical device providers, and raw material suppliers, all of whom play a significant role in the development and distribution of treatments. Limited suppliers for specialized medical devices or patented drugs can increase their influence on pricing and availability in the market.

What is the bargaining power of buyers in the Nocturia Market in 2025?

The bargaining power of buyers is moderate to low. While patients are the end consumers, they often have limited options for nocturia treatments, particularly for more advanced therapies. However, healthcare providers and insurers have a higher bargaining power in terms of deciding treatment availability and pricing, especially when negotiating with pharmaceutical companies.

What is the threat of substitute products or services in the Nocturia Market in 2025?

The threat of substitutes is moderate. Non-pharmaceutical interventions, such as lifestyle changes, behavioral therapies, and alternative medicine, could provide substitutes to traditional nocturia treatments. However, these alternatives may not always offer the same level of effectiveness, which keeps the demand for conventional medical treatments strong.

What is the intensity of competitive rivalry in the Nocturia Market in 2025?

The competitive rivalry in the nocturia market is high. Several established pharmaceutical companies, as well as newer entrants, are competing to offer more effective treatments and innovative solutions. With the increasing prevalence of nocturia and advancements in treatment options, companies will likely intensify their efforts to capture market share through product differentiation and research.

What are the key raw materials required in the Nocturia Market in 2025?

Key raw materials include active pharmaceutical ingredients (APIs) for medications used in treating nocturia, specialized materials for medical devices, and diagnostic equipment components. Research and development also rely on clinical trial data and patient samples to ensure treatments are effective and safe.

Who are the major suppliers in the Nocturia Market in 2025?

Major suppliers include large pharmaceutical companies that manufacture nocturia medications, medical device manufacturers that produce diagnostic and monitoring tools, and research organizations that provide data and insights into new treatment options. Regulatory bodies also act as suppliers, providing the necessary approvals and certifications to ensure treatments reach the market.

What are the technological advancements influencing the upstream segment of the Nocturia Market in 2025?

Technological advancements, such as the development of more precise diagnostic tools, non-invasive treatment methods, and drug delivery systems, are significantly impacting the upstream segment. Innovations in AI and telemedicine for remote patient monitoring are also influencing how suppliers develop and deliver treatments for nocturia.

How do regulatory factors impact the upstream activities in the Nocturia Market in 2025?

Regulatory factors, such as approval processes from health authorities like the FDA or EMA, play a crucial role in shaping upstream activities. Stringent regulations for drug manufacturing, medical devices, and clinical trials mean that suppliers must invest in ensuring compliance to avoid delays in bringing products to market.

What challenges do suppliers face in the Nocturia Market in 2025?

Suppliers face challenges such as high R&D costs, stringent regulatory requirements, and the need for continuous innovation to meet patient demands. Competition from generic drugs and the need to maintain pricing strategies that remain accessible to patients while ensuring profitability also create difficulties. Additionally, ensuring the scalability of production to meet growing demand in emerging markets can be a significant challenge.

What are the key activities in the midstream segment of the Nocturia Market in 2025?

Key activities in the midstream segment include the manufacturing, packaging, and distribution of nocturia treatments and medical devices. This stage also involves ensuring that products are transported to healthcare providers, pharmacies, and hospitals efficiently. Additionally, partnerships between pharmaceutical companies and distribution networks play a critical role in making treatments accessible.

What role do distributors and healthcare providers play in the Nocturia Market in 2025?

Distributors and healthcare providers act as vital intermediaries in the midstream market. Distributors ensure that nocturia medications and devices reach healthcare settings, while healthcare providers, including urologists and general practitioners, deliver treatments and manage patient care. Their feedback can also drive improvements in the effectiveness of therapies.

What challenges are faced in the midstream segment of the Nocturia Market in 2025?

The challenges in the midstream segment include managing supply chain disruptions, ensuring the availability of treatments, and addressing logistical issues in distributing specialized medications or devices. Regulatory challenges can also arise, especially with new treatment formulations or medical devices requiring certifications. Furthermore, regional disparities in healthcare infrastructure can create access issues.

How do technological innovations impact the midstream segment of the Nocturia Market in 2025?

Technological innovations such as advanced tracking systems, automated distribution, and telemedicine are helping streamline the midstream segment. Remote monitoring and digital health solutions are improving the way healthcare providers manage nocturia, while smart packaging and connected devices are making distribution more efficient and patient-centric.

What impact does market competition have on the midstream segment in the Nocturia Market in 2025?

Competition in the midstream segment drives improvements in distribution efficiency and cost-effectiveness. Pharmaceutical companies and device manufacturers are likely to compete for market share by offering better prices, faster delivery, and innovative solutions. This competition can also encourage faster adoption of new treatments in healthcare settings, benefiting patients.

What are the key activities in the downstream segment of the Nocturia Market in 2025?

Key activities in the downstream segment include patient care, treatment administration, and follow-up monitoring. This stage also involves patient education on managing nocturia symptoms, ensuring adherence to prescribed therapies, and utilizing support services like counseling or lifestyle management. Additionally, pharmacies and hospitals play a critical role in dispensing medications and medical devices.

What role do patients and healthcare providers play in the downstream segment of the Nocturia Market in 2025?

Patients are the end consumers, seeking treatment to manage nocturia symptoms and improve quality of life. Healthcare providers, such as urologists, general practitioners, and nursing staff, directly administer treatments, provide consultations, and monitor patient progress. They also offer support for managing side effects or adjusting treatment regimens as needed.

What challenges exist in the downstream segment of the Nocturia Market in 2025?

Challenges include patient non-compliance due to treatment side effects or the complexity of management, which can impact the overall effectiveness of therapies. There may also be a lack of awareness or stigma around nocturia, preventing individuals from seeking care. Additionally, limited access to healthcare services in rural or underserved areas could hinder patient outcomes.

How do technological advancements impact the downstream segment of the Nocturia Market in 2025?

Technological advancements such as remote monitoring devices, digital health apps, and telemedicine platforms are helping healthcare providers offer more personalized care. These innovations enable continuous tracking of nocturia symptoms, improve communication between patients and doctors, and increase the accessibility of treatment, particularly in remote or underserved areas.

What impact does competition have on the downstream segment of the Nocturia Market in 2025?

Competition in the downstream segment will lead to more diverse treatment options, allowing patients and healthcare providers to choose from a range of therapies. This increased competition can also drive improvements in patient care, as companies and healthcare providers strive to offer better outcomes, support services, and access to treatments.

Chapter 1, to describe Nocturia product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nocturia, with revenue, gross margin and global market share of Nocturia from 2018 to 2023.
Chapter 3, the Nocturia competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nocturia market forecast, by regions, type and sale channels, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Nocturia.
Chapter 13, to describe Nocturia research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Nocturia
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Nocturia by Type
       1.3.1 Overview: Global Nocturia Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global Nocturia Consumption Value Market Share by Type in 2022
       1.3.3 Desmopressin
       1.3.4 Anticholinergic Drugs
       1.3.5 Alpha Blockers
       1.3.6 Diuretics
       1.3.7 Others
   1.4 Global Nocturia Market by Sale Channels
       1.4.1 Overview: Global Nocturia Market Size by Sale Channels: 2018 Versus 2022 Versus 2029
       1.4.2 Hospital Pharmacies
       1.4.3 Retail Pharmacies
       1.4.4 Online Pharmacies
   1.5 Global Nocturia Market Size & Forecast
   1.6 Global Nocturia Market Size and Forecast by Region
       1.6.1 Global Nocturia Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Nocturia Market Size by Region, (2018-2029)
       1.6.3 North America Nocturia Market Size and Prospect (2018-2029)
       1.6.4 Europe Nocturia Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Nocturia Market Size and Prospect (2018-2029)
       1.6.6 South America Nocturia Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Nocturia Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 Astellas Pharma
       2.1.1 Astellas Pharma Details
       2.1.2 Astellas Pharma Major Business
       2.1.3 Astellas Pharma Nocturia Product and Solutions
       2.1.4 Astellas Pharma Nocturia Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Astellas Pharma Recent Developments and Future Plans
   2.2 Allergan
       2.2.1 Allergan Details
       2.2.2 Allergan Major Business
       2.2.3 Allergan Nocturia Product and Solutions
       2.2.4 Allergan Nocturia Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Allergan Recent Developments and Future Plans
   2.3 Ferring Pharmaceuticals
       2.3.1 Ferring Pharmaceuticals Details
       2.3.2 Ferring Pharmaceuticals Major Business
       2.3.3 Ferring Pharmaceuticals Nocturia Product and Solutions
       2.3.4 Ferring Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Ferring Pharmaceuticals Recent Developments and Future Plans
   2.4 Eli Lilly
       2.4.1 Eli Lilly Details
       2.4.2 Eli Lilly Major Business
       2.4.3 Eli Lilly Nocturia Product and Solutions
       2.4.4 Eli Lilly Nocturia Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Eli Lilly Recent Developments and Future Plans
   2.5 GlaxoSmithKline
       2.5.1 GlaxoSmithKline Details
       2.5.2 GlaxoSmithKline Major Business
       2.5.3 GlaxoSmithKline Nocturia Product and Solutions
       2.5.4 GlaxoSmithKline Nocturia Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 GlaxoSmithKline Recent Developments and Future Plans
   2.6 Sanofi
       2.6.1 Sanofi Details
       2.6.2 Sanofi Major Business
       2.6.3 Sanofi Nocturia Product and Solutions
       2.6.4 Sanofi Nocturia Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Sanofi Recent Developments and Future Plans
   2.7 Pfizer
       2.7.1 Pfizer Details
       2.7.2 Pfizer Major Business
       2.7.3 Pfizer Nocturia Product and Solutions
       2.7.4 Pfizer Nocturia Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Pfizer Recent Developments and Future Plans
   2.8 Abbott
       2.8.1 Abbott Details
       2.8.2 Abbott Major Business
       2.8.3 Abbott Nocturia Product and Solutions
       2.8.4 Abbott Nocturia Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Abbott Recent Developments and Future Plans
   2.9 Teva
       2.9.1 Teva Details
       2.9.2 Teva Major Business
       2.9.3 Teva Nocturia Product and Solutions
       2.9.4 Teva Nocturia Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Teva Recent Developments and Future Plans
   2.10 Mylan 
       2.10.1 Mylan Details
       2.10.2 Mylan Major Business
       2.10.3 Mylan Nocturia Product and Solutions
       2.10.4 Mylan Nocturia Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Mylan Recent Developments and Future Plans
   2.11 Johnson & Johnson
       2.11.1 Johnson & Johnson Details
       2.11.2 Johnson & Johnson Major Business
       2.11.3 Johnson & Johnson Nocturia Product and Solutions
       2.11.4 Johnson & Johnson Nocturia Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Johnson & Johnson Recent Developments and Future Plans
   2.12 Hainan Zhonghe Pharmaceutical
       2.12.1 Hainan Zhonghe Pharmaceutical Details
       2.12.2 Hainan Zhonghe Pharmaceutical Major Business
       2.12.3 Hainan Zhonghe Pharmaceutical Nocturia Product and Solutions
       2.12.4 Hainan Zhonghe Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Hainan Zhonghe Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Nocturia Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Nocturia by Company Revenue
       3.2.2 Top 3 Nocturia Players Market Share in 2022
       3.2.3 Top 6 Nocturia Players Market Share in 2022
   3.3 Nocturia Market: Overall Company Footprint Analysis
       3.3.1 Nocturia Market: Region Footprint
       3.3.2 Nocturia Market: Company Product Type Footprint
       3.3.3 Nocturia Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global Nocturia Consumption Value and Market Share by Type (2018-2023)
   4.2 Global Nocturia Market Forecast by Type (2024-2029)

5 Market Size Segment by Sale Channels

   5.1 Global Nocturia Consumption Value Market Share by Sale Channels (2018-2023)
   5.2 Global Nocturia Market Forecast by Sale Channels (2024-2029)

6 North America

   6.1 North America Nocturia Consumption Value by Type (2018-2029)
   6.2 North America Nocturia Consumption Value by Sale Channels (2018-2029)
   6.3 North America Nocturia Market Size by Country
       6.3.1 North America Nocturia Consumption Value by Country (2018-2029)
       6.3.2 United States Nocturia Market Size and Forecast (2018-2029)
       6.3.3 Canada Nocturia Market Size and Forecast (2018-2029)
       6.3.4 Mexico Nocturia Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Nocturia Consumption Value by Type (2018-2029)
   7.2 Europe Nocturia Consumption Value by Sale Channels (2018-2029)
   7.3 Europe Nocturia Market Size by Country
       7.3.1 Europe Nocturia Consumption Value by Country (2018-2029)
       7.3.2 Germany Nocturia Market Size and Forecast (2018-2029)
       7.3.3 France Nocturia Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Nocturia Market Size and Forecast (2018-2029)
       7.3.5 Russia Nocturia Market Size and Forecast (2018-2029)
       7.3.6 Italy Nocturia Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Nocturia Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific Nocturia Consumption Value by Sale Channels (2018-2029)
   8.3 Asia-Pacific Nocturia Market Size by Region
       8.3.1 Asia-Pacific Nocturia Consumption Value by Region (2018-2029)
       8.3.2 China Nocturia Market Size and Forecast (2018-2029)
       8.3.3 Japan Nocturia Market Size and Forecast (2018-2029)
       8.3.4 South Korea Nocturia Market Size and Forecast (2018-2029)
       8.3.5 India Nocturia Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Nocturia Market Size and Forecast (2018-2029)
       8.3.7 Australia Nocturia Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Nocturia Consumption Value by Type (2018-2029)
   9.2 South America Nocturia Consumption Value by Sale Channels (2018-2029)
   9.3 South America Nocturia Market Size by Country
       9.3.1 South America Nocturia Consumption Value by Country (2018-2029)
       9.3.2 Brazil Nocturia Market Size and Forecast (2018-2029)
       9.3.3 Argentina Nocturia Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Nocturia Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa Nocturia Consumption Value by Sale Channels (2018-2029)
   10.3 Middle East & Africa Nocturia Market Size by Country
       10.3.1 Middle East & Africa Nocturia Consumption Value by Country (2018-2029)
       10.3.2 Turkey Nocturia Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Nocturia Market Size and Forecast (2018-2029)
       10.3.4 UAE Nocturia Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Nocturia Market Drivers
   11.2 Nocturia Market Restraints
   11.3 Nocturia Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Nocturia Industry Chain
   12.2 Nocturia Upstream Analysis
   12.3 Nocturia Midstream Analysis
   12.4 Nocturia Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global Nocturia Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Nocturia Consumption Value by Sale Channels, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Nocturia Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Nocturia Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. Astellas Pharma Company Information, Head Office, and Major Competitors
   Table 6. Astellas Pharma Major Business
   Table 7. Astellas Pharma Nocturia Product and Solutions
   Table 8. Astellas Pharma Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. Astellas Pharma Recent Developments and Future Plans
   Table 10. Allergan Company Information, Head Office, and Major Competitors
   Table 11. Allergan Major Business
   Table 12. Allergan Nocturia Product and Solutions
   Table 13. Allergan Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. Allergan Recent Developments and Future Plans
   Table 15. Ferring Pharmaceuticals Company Information, Head Office, and Major Competitors
   Table 16. Ferring Pharmaceuticals Major Business
   Table 17. Ferring Pharmaceuticals Nocturia Product and Solutions
   Table 18. Ferring Pharmaceuticals Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. Ferring Pharmaceuticals Recent Developments and Future Plans
   Table 20. Eli Lilly Company Information, Head Office, and Major Competitors
   Table 21. Eli Lilly Major Business
   Table 22. Eli Lilly Nocturia Product and Solutions
   Table 23. Eli Lilly Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. Eli Lilly Recent Developments and Future Plans
   Table 25. GlaxoSmithKline Company Information, Head Office, and Major Competitors
   Table 26. GlaxoSmithKline Major Business
   Table 27. GlaxoSmithKline Nocturia Product and Solutions
   Table 28. GlaxoSmithKline Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. GlaxoSmithKline Recent Developments and Future Plans
   Table 30. Sanofi Company Information, Head Office, and Major Competitors
   Table 31. Sanofi Major Business
   Table 32. Sanofi Nocturia Product and Solutions
   Table 33. Sanofi Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. Sanofi Recent Developments and Future Plans
   Table 35. Pfizer Company Information, Head Office, and Major Competitors
   Table 36. Pfizer Major Business
   Table 37. Pfizer Nocturia Product and Solutions
   Table 38. Pfizer Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 39. Pfizer Recent Developments and Future Plans
   Table 40. Abbott Company Information, Head Office, and Major Competitors
   Table 41. Abbott Major Business
   Table 42. Abbott Nocturia Product and Solutions
   Table 43. Abbott Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 44. Abbott Recent Developments and Future Plans
   Table 45. Teva Company Information, Head Office, and Major Competitors
   Table 46. Teva Major Business
   Table 47. Teva Nocturia Product and Solutions
   Table 48. Teva Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 49. Teva Recent Developments and Future Plans
   Table 50. Mylan Company Information, Head Office, and Major Competitors
   Table 51. Mylan Major Business
   Table 52. Mylan Nocturia Product and Solutions
   Table 53. Mylan Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 54. Mylan Recent Developments and Future Plans
   Table 55. Johnson & Johnson Company Information, Head Office, and Major Competitors
   Table 56. Johnson & Johnson Major Business
   Table 57. Johnson & Johnson Nocturia Product and Solutions
   Table 58. Johnson & Johnson Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 59. Johnson & Johnson Recent Developments and Future Plans
   Table 60. Hainan Zhonghe Pharmaceutical Company Information, Head Office, and Major Competitors
   Table 61. Hainan Zhonghe Pharmaceutical Major Business
   Table 62. Hainan Zhonghe Pharmaceutical Nocturia Product and Solutions
   Table 63. Hainan Zhonghe Pharmaceutical Nocturia Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 64. Hainan Zhonghe Pharmaceutical Recent Developments and Future Plans
   Table 65. Global Nocturia Revenue (USD Million) by Players (2018-2023)
   Table 66. Global Nocturia Revenue Share by Players (2018-2023)
   Table 67. Breakdown of Nocturia by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 68. Market Position of Players in Nocturia, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 69. Head Office of Key Nocturia Players
   Table 70. Nocturia Market: Company Product Type Footprint
   Table 71. Nocturia Market: Company Product Application Footprint
   Table 72. Nocturia New Market Entrants and Barriers to Market Entry
   Table 73. Nocturia Mergers, Acquisition, Agreements, and Collaborations
   Table 74. Global Nocturia Consumption Value (USD Million) by Type (2018-2023)
   Table 75. Global Nocturia Consumption Value Share by Type (2018-2023)
   Table 76. Global Nocturia Consumption Value Forecast by Type (2024-2029)
   Table 77. Global Nocturia Consumption Value by Sale Channels (2018-2023)
   Table 78. Global Nocturia Consumption Value Forecast by Sale Channels (2024-2029)
   Table 79. North America Nocturia Consumption Value by Type (2018-2023) & (USD Million)
   Table 80. North America Nocturia Consumption Value by Type (2024-2029) & (USD Million)
   Table 81. North America Nocturia Consumption Value by Sale Channels (2018-2023) & (USD Million)
   Table 82. North America Nocturia Consumption Value by Sale Channels (2024-2029) & (USD Million)
   Table 83. North America Nocturia Consumption Value by Country (2018-2023) & (USD Million)
   Table 84. North America Nocturia Consumption Value by Country (2024-2029) & (USD Million)
   Table 85. Europe Nocturia Consumption Value by Type (2018-2023) & (USD Million)
   Table 86. Europe Nocturia Consumption Value by Type (2024-2029) & (USD Million)
   Table 87. Europe Nocturia Consumption Value by Sale Channels (2018-2023) & (USD Million)
   Table 88. Europe Nocturia Consumption Value by Sale Channels (2024-2029) & (USD Million)
   Table 89. Europe Nocturia Consumption Value by Country (2018-2023) & (USD Million)
   Table 90. Europe Nocturia Consumption Value by Country (2024-2029) & (USD Million)
   Table 91. Asia-Pacific Nocturia Consumption Value by Type (2018-2023) & (USD Million)
   Table 92. Asia-Pacific Nocturia Consumption Value by Type (2024-2029) & (USD Million)
   Table 93. Asia-Pacific Nocturia Consumption Value by Sale Channels (2018-2023) & (USD Million)
   Table 94. Asia-Pacific Nocturia Consumption Value by Sale Channels (2024-2029) & (USD Million)
   Table 95. Asia-Pacific Nocturia Consumption Value by Region (2018-2023) & (USD Million)
   Table 96. Asia-Pacific Nocturia Consumption Value by Region (2024-2029) & (USD Million)
   Table 97. South America Nocturia Consumption Value by Type (2018-2023) & (USD Million)
   Table 98. South America Nocturia Consumption Value by Type (2024-2029) & (USD Million)
   Table 99. South America Nocturia Consumption Value by Sale Channels (2018-2023) & (USD Million)
   Table 100. South America Nocturia Consumption Value by Sale Channels (2024-2029) & (USD Million)
   Table 101. South America Nocturia Consumption Value by Country (2018-2023) & (USD Million)
   Table 102. South America Nocturia Consumption Value by Country (2024-2029) & (USD Million)
   Table 103. Middle East & Africa Nocturia Consumption Value by Type (2018-2023) & (USD Million)
   Table 104. Middle East & Africa Nocturia Consumption Value by Type (2024-2029) & (USD Million)
   Table 105. Middle East & Africa Nocturia Consumption Value by Sale Channels (2018-2023) & (USD Million)
   Table 106. Middle East & Africa Nocturia Consumption Value by Sale Channels (2024-2029) & (USD Million)
   Table 107. Middle East & Africa Nocturia Consumption Value by Country (2018-2023) & (USD Million)
   Table 108. Middle East & Africa Nocturia Consumption Value by Country (2024-2029) & (USD Million)
   Table 109. Nocturia Raw Material
   Table 110. Key Suppliers of Nocturia Raw Materials

List of Figures

   Figure 1. Nocturia Picture
   Figure 2. Global Nocturia Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Nocturia Consumption Value Market Share by Type in 2022
   Figure 4. Desmopressin
   Figure 5. Anticholinergic Drugs
   Figure 6. Alpha Blockers
   Figure 7. Diuretics
   Figure 8. Others
   Figure 9. Global Nocturia Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 10. Nocturia Consumption Value Market Share by Sale Channels in 2022
   Figure 11. Hospital Pharmacies Picture
   Figure 12. Retail Pharmacies Picture
   Figure 13. Online Pharmacies Picture
   Figure 14. Global Nocturia Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 15. Global Nocturia Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 16. Global Market Nocturia Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 17. Global Nocturia Consumption Value Market Share by Region (2018-2029)
   Figure 18. Global Nocturia Consumption Value Market Share by Region in 2022
   Figure 19. North America Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 20. Europe Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 21. Asia-Pacific Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 22. South America Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 23. Middle East and Africa Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 24. Global Nocturia Revenue Share by Players in 2022
   Figure 25. Nocturia Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 26. Global Top 3 Players Nocturia Market Share in 2022
   Figure 27. Global Top 6 Players Nocturia Market Share in 2022
   Figure 28. Global Nocturia Consumption Value Share by Type (2018-2023)
   Figure 29. Global Nocturia Market Share Forecast by Type (2024-2029)
   Figure 30. Global Nocturia Consumption Value Share by Sale Channels (2018-2023)
   Figure 31. Global Nocturia Market Share Forecast by Sale Channels (2024-2029)
   Figure 32. North America Nocturia Consumption Value Market Share by Type (2018-2029)
   Figure 33. North America Nocturia Consumption Value Market Share by Sale Channels (2018-2029)
   Figure 34. North America Nocturia Consumption Value Market Share by Country (2018-2029)
   Figure 35. United States Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 36. Canada Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 37. Mexico Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 38. Europe Nocturia Consumption Value Market Share by Type (2018-2029)
   Figure 39. Europe Nocturia Consumption Value Market Share by Sale Channels (2018-2029)
   Figure 40. Europe Nocturia Consumption Value Market Share by Country (2018-2029)
   Figure 41. Germany Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 42. France Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 43. United Kingdom Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 44. Russia Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 45. Italy Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 46. Asia-Pacific Nocturia Consumption Value Market Share by Type (2018-2029)
   Figure 47. Asia-Pacific Nocturia Consumption Value Market Share by Sale Channels (2018-2029)
   Figure 48. Asia-Pacific Nocturia Consumption Value Market Share by Region (2018-2029)
   Figure 49. China Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 50. Japan Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 51. South Korea Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 52. India Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 53. Southeast Asia Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 54. Australia Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 55. South America Nocturia Consumption Value Market Share by Type (2018-2029)
   Figure 56. South America Nocturia Consumption Value Market Share by Sale Channels (2018-2029)
   Figure 57. South America Nocturia Consumption Value Market Share by Country (2018-2029)
   Figure 58. Brazil Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 59. Argentina Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 60. Middle East and Africa Nocturia Consumption Value Market Share by Type (2018-2029)
   Figure 61. Middle East and Africa Nocturia Consumption Value Market Share by Sale Channels (2018-2029)
   Figure 62. Middle East and Africa Nocturia Consumption Value Market Share by Country (2018-2029)
   Figure 63. Turkey Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 64. Saudi Arabia Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 65. UAE Nocturia Consumption Value (2018-2029) & (USD Million)
   Figure 66. Nocturia Market Drivers
   Figure 67. Nocturia Market Restraints
   Figure 68. Nocturia Market Trends
   Figure 69. Porters Five Forces Analysis
   Figure 70. Manufacturing Cost Structure Analysis of Nocturia in 2022
   Figure 71. Manufacturing Process Analysis of Nocturia
   Figure 72. Nocturia Industrial Chain
   Figure 73. Methodology
   Figure 74. Research Process and Data Source